Dexcom · 1 month ago
Intern I - Software Test Development Engineering
San Diego, California
Internship
Onsite
Intern
$27/hr - $29/hr
Start in 2026 SummerDexcom Corporation is a pioneer and global leader in continuous glucose monitoring (CGM). They are seeking an intern to work on impactful projects that support people living with diabetes, focusing on automation of testing and collaboration with engineers.
DiabetesHealth DiagnosticsMedical DeviceSensor
Responsibilities
You will be working on a targeted project to explore, start and complete
You will be working directly with the engineers on the team
You will be designing a solution to automate an area of testing
You will be writing code on a regular basis
Qualification
Required
Requires a high school diploma/certificate or equivalent
Must be a currently enrolled student at an accredited college or university in a STEM discipline with an expected graduation date of December 2026 or later
You must be able to write code
You must be able to communicate with other engineers and developers, to learn, understand the problem, and collaborate on a solution
Preferred
Experience with Python is a plus
Experience with AI development is a plus
Experience or knowledge of GCP is a plus
Benefits
Participation in a targeted Learning Series that encourages professional development topics and provides insight into Dexcom's culture and career opportunities.
Engagement in Social Events, Intern Recognition Awards, Paid Holidays, and more!
Company
Dexcom
Dexcom develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management.
Founded in 1999
10001+ employees
H1B Sponsorship
Dexcom has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (54)
2024 (41)
2023 (67)
2022 (75)
2021 (49)
2020 (36)
Funding
Current Stage
Public CompanyTotal Funding
$2.16BKey Investors
RWI Group
2023-05-02Post Ipo Debt· $1B
2020-05-12Post Ipo Debt
2018-11-01Post Ipo Equity· $750M
Leadership Team
Jacob Leach
Chief Operating Officer
Matt Dolan
Executive Vice President, Strategy, Corporate Development & Dexcom Labs
Recent News
San Diego Union-Tribune
2026-01-08
The Motley Fool
2025-12-30
Company data provided by crunchbase